This is an ongoing concern with gene therapy and depends to a certain degree on the cell turn-over in the target tissue and if you manage to hit progenitors/stem cells.
It is logical because of the nature of the disease and application of this approach. However, the clinical use of gene therapy, especially by somatic cells, needs to more investigation.